Advanced Materials · 2023 · 66 citations · 44 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTumor MicroenvironmentCancer Drug DeliveryCancer NanomedicineDrug EncapsulationNanomaterials For Drug DeliveryNanomedicinePh-responsive Drug DeliveryNanocarriersNanoparticle DeliveryNanoparticle-based Responsive ReleaseNanoparticlesPh-responsive DeliveryPh-sensitive NanoparticlesSystemic DeliverySystemic Drug Delivery
Abstract Nanotechnology is revolutionizing cancer therapy, and catalyzes the emerging of ion‐involved cancer‐therapeutic modality, which unfortunately suffers from undesirable nanocarriers for efficient intracellular ion delivery. To radically extricate from this critical issue, the glutathione (GSH)‐responsive organosilica network is employed to lock the liquid drops at the nanoscale via a general bottom‐up strategy to achieve the systemic delivery of “ion drugs”. In this work, a sulfate radical generation donor (Na 2 S 2 O 8 ), as a paradigm “ion drug”, is entrapped into this liquid nanoparticle for efficiently delivering to the tumor region. After further surface engineering with pH‐responsive tannic acid‐Fe 2+ framework, these liquid nanoparticles achieve tumor‐microenvironmental pH/GSH‐dual responsive ion release (Fe 2+ /Na + /S 2 O 8 2− ) after reaching the tumor sites, where the Fe 2+ further triggers S 2 O 8 2− to generate toxic •SO 4 − and •OH, effectively executing cancer cell ferroptosis (Fe 2+ , reactive oxygen species—ROS) and pyroptosis (Na + , ROS). Such a tumor‐responsive/specific liquid nanoplatform is highly instructive for further ion‐mediated nanomedicine and disease treatment.
44
Copper induces cell death by targeting lipoylated TCA cycle proteins
Peter Tsvetkov, Shannon Coy, Boryana Petrova et al. · Science · 2022 · 4.7K citations · Full text
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo, Liying Wang, Yu Chen et al. · Nature Communications · 2017 · 1.3K citations · Full text